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This article includes data from three prospective longitudinal human
cohorts of prenatal marijuana exposure (PME) and offspring outcomes
from the fetal period through young adulthood. The table herein
contains an overview of the major adverse effects associated with PME
from the following human cohorts: (1) The Ottawa Prenatal Pro-
spective Study (OPPS); (2) The Maternal Health Practices and Child
Development Study (MHPCD); and (3) The Generation R Study (Gen
R). In the OPPS, fetal gestational age was measured and age-
appropriate standardized neuropsychological instruments were used
to assess neonatal responses, and infant–child and adolescent–young
adult cognitive and behavioral skills. In the MHPCD, birth length and
weight, neonatal body length, and infant–child sleep, cognition, and
behavioral parameters were measured. In the Gen R, birth weight and
growth were measured, as were infant–child attention and aggression.
The data in this article are in support of our report entitled “Prenatal
Cannabis Exposure - The "First Hit" to the Endocannabinoid System”
(K.A. Richardson, A.K. Hester, G.L. McLemore, 2016) [13].
& 2016 Published by Elsevier Inc. This is an open access article under
the CC BY license (http://creativecommons.org/licenses/by/4.0/).is an open access article under the CC BY license
/j.ntt.2016.08.003
.edu (G.L. McLemore), Kimberlei.Richardson@howard.edu (K.A. Richardson).
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H
D
E
E
DSubject area Biologyore speciﬁc sub-
ject areaPrenatal marijuana exposure and the ﬁrst hit to the endogenous cannabinoid
system [13]ype of data Table
ow data was
acquiredProspective longitudinal human cohort data derived from the OPPS, MHPCD, and
Gen R investigations with follow-up assessments of offspring from the fetal
period through young adulthoodata format Formatted
xperimental
factorsPrenatal marijuana exposure and offspring outcomes from the fetal period
through young adulthoodxperimental
featuresThe OPPS assessed the effects of prenatal tobacco, alcohol, and marijuana
exposure in low-risk, middle-class, Caucasian Canadian women. The MHPCD
assessed the effects of prenatal alcohol and marijuana exposure in Caucasian
and African American women of low socioeconomic status. The Gen R assessed
the effects of prenatal marijuana exposure in a multi-ethnic cohort of women in
Rotterdam, The Netherlands.ata source
locationN/Aata accessibility Data is within this article.D
Value of the data
 This dataset is of value to the scientiﬁc community because it can serve as a reference for other
researchers interested in the adverse effects of prenatal marijuana use on offspring outcomes from
the fetal period through young adulthood.
 These data are of value to the scientiﬁc community because they can open doors for new colla-
borative research efforts between physician-scientists (neonatologists), psychiatrists, drug addic-
tion counselors, and/or basic drug abuse and addiction research scientists.
 These data highlight the need for more extensive basic, clinical, and translational research on the
impact of prenatal marijuana exposure on the development of cognitive and psychological pro-
cesses in exposed offspring.
 These data highlight the need for researchers to develop novel strategies for improving the health
of and healthcare for pregnant women and their children.1. Data
The data described herein are adapted from three articles [1,10,13,15]. This table highlights the
cognitive, psychological, and behavioral effects of prenatal marijuana exposure with follow-up
assessments of offspring outcomes from the fetal period through young adulthood (Table 1).2. Experimental design, materials, and methods
The OPPS assessed the effects of prenatal tobacco, alcohol, and marijuana exposure in a low-risk,
middle-class, mostly Caucasian, and predominantly Canadian cohort of women. The offspring of
participants were followed until the age of 18–22 years [6–8].
The MHPCD assessed the effects of prenatal alcohol and marijuana exposure in a cohort of Cau-
casian (43%) and African American (57%) women of low socioeconomic status who were
Table 1
Three human prospective longitudinal cohorts of prenatal marijuana exposed offspring from the fetal period through young adulthood.
Study Fetus Neonate Infant–Child Adolescence–Young adult
Ottawa Prenatal Prospective Study (OPPS)
[6,7,8]
↓ Gestational age ↓ Response to light
↑ Startle response
↑ Tremors
3 years:
↑ Motor skills
4 years:
↓ Memory
↓ Verbal scores
6 years:
↓ Attention
↑ Impulsivity
↑ Hyperactivity
9-12 years:
↓ Visual perception
↑ Impulsivity
13-16 years:
↓ Concentration
↓ Visual memory
↓ Verbal reasoning
18-22 years:
↓ Response inhibition
Response inhibition as mea-
sured via fMRI:
↓ Cerebellum activity
↑ Bilateral PFC activity
↑ Premotor cortex
activity
Working memory as measured
via fMRI:
↓ Medial PFC activity
↓ Dorsolateral PFC
activity
↓ Ventrolateral PFC
activity
↑ Left medial PFC
activity
↑ Inferior frontal gyrus activity
↑ Left cerebellum
activity
Maternal Health Practices and Child Development Study
(MHPCD)
[2,3]
↓ Birth length (after 1st trimester
exposure only)
↑ Birth weight (after 3rd trimester
exposure)
↓ Body length
Subpopulation:
slight changes in
EEG traces
9 months:
↓ Mental
development
↓ BSID scores
3 years:
↓ Short-
term memory
10 years:
↓ Abstract reasoning
↓ Visual reasoning
↓ Concentration
↓ Internalization
(Implosion)
↓Learning and memory
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Table 1 (continued )
Study Fetus Neonate Infant–Child Adolescence–Young adult
↓ Verbal reason-
ing
(African Amer-
icans only)
3 years:
↓ Sleep efﬁciency
↑ Nocturnal
arousals
↑ Wake-time
after
sleep onset
6 years:
↓ Concentration
↓ Overall IQ score
↓ Verbal
reasoning
↓ Quantitative
reasoning
↓ Short-
term memory
↑ Impulsivity
↑ Hyperactivity
↑ Delinquency
↓ IQ score
↑ Externalization
(Explosion)
↑ Depression
↑ Impulsivity
↑ Hyperactivity
↑ Delinquency
14 years:
↑ Delinquency
16 years:
slight ↓ in ﬁne motor
coordination
slight ↑ in visual-motor
coordination
Subsample of the Generation R Study, the Generation R
Focus Study [5,9,11,12]
↓ Birth weight
↑ Growth (from 2nd trimester to
parturition)
18 months:
↓ Attention
↑ Aggression (for
girls only)
Adapted from Calvigioni et al. [1], Huizink [10], and Wu et al. [15].
↑ - Increased; ↓ - Decreased; BSID - Bayley Scales of Infant Development; fMRI - Functional Magnetic Resonance Imaging; Response inhibition - an indicator of executive control, refers to
one’s ability to suppress inappropriate actions or impulses, which undergird goal-oriented and adaptable responses to dynamic surroundings [14].
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G.L. McLemore, K.A. Richardson / Data in Brief 9 (2016) 753–757 757predominantly single (71%) in Pittsburgh, Pennsylvania, USA. Follow-up assessment data of offspring
have been reported up to age 14 [2,3].
The Gen R is an ongoing, population-based, large-scaled, multi-ethnic prospective cohort inves-
tigation of prenatal marijuana exposed offspring from the fetal period to early childhood in Rotter-
dam, The Netherlands. [4,5,9,11,12].Transparency document. Supporting information
Transparency data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.10.005.References
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